
Angel Investor
Lord Moynihan of Chelsea has been an angel investor in the following startups:

Get ready for a groundbreaking revolution in precision medicine for coronary artery disease as PlaqueTec secures £6.4M in funding to advance their innovative biomarker discovery tool, Biocarta®, and ongoing Biopattern trial, aiming to improve understanding of CAD pathobiology and individual variations.
Lord Moynihan of Chelsea is an angel investor based in London, in the UK.
Featured Angel Investors